TET2 and acute myeloid leukemia: Whereas one report indicated that TET2 mutation in AML is associated with a DNA hypermethylation phenotype [73], other data suggested that bone marrow samples from patients with TET2 mutations have low 5hmC levels and DNA hypomethylation [78,79].